199 related articles for article (PubMed ID: 32221981)
1. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
[TBL] [Abstract][Full Text] [Related]
2. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
3. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
4. Medical device recalls and the FDA approval process.
Zuckerman DM; Brown P; Nissen SE
Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
[TBL] [Abstract][Full Text] [Related]
5. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
6. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
7. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
8. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
[TBL] [Abstract][Full Text] [Related]
9. Mapping the genealogy of medical device predicates in the United States.
Pai DB
PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
[TBL] [Abstract][Full Text] [Related]
10. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
11. Transparency and Dermatologic Device Approval by the US Food and Drug Administration.
Ezaldein HH; Scott JF; Yin ES; Ventura A; DeRuyter NP; Leffell DJ
JAMA Dermatol; 2018 Mar; 154(3):273-280. PubMed ID: 29365020
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
[TBL] [Abstract][Full Text] [Related]
13. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Obstetric and Gynecologic Food and Drug Administration Device Approvals and Recalls.
Galhotra S; Maurice J
J Minim Invasive Gynecol; 2018; 25(7):1281-1288. PubMed ID: 29653261
[TBL] [Abstract][Full Text] [Related]
15. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A; Premkumar A
HSS J; 2022 Nov; 18(4):462-468. PubMed ID: 36258781
[No Abstract] [Full Text] [Related]
16. The Food and Drug Administration's (FDA's) 510(k) Process: A Systematic Review of 1000 Cases.
Shah P; Olavarria O; Dhanani N; Ciomperlik H; Mohr C; Bernardi K; Neela N; Coelho R; Ali Z; Prabhu A; Liang MK
Am J Med; 2023 Feb; 136(2):172-178.e14. PubMed ID: 36170936
[TBL] [Abstract][Full Text] [Related]
17. Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019.
Talati IA; Parsa KM; Gao WZ
Otolaryngol Head Neck Surg; 2022 Nov; 167(5):832-838. PubMed ID: 35290135
[TBL] [Abstract][Full Text] [Related]
18. Shoulder arthroplasty device clearance: an ancestral network analysis.
Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
[TBL] [Abstract][Full Text] [Related]
19. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cardiovascular and noncardiovascular medical device recalls.
Somberg JC; McEwen P; Molnar J
Am J Cardiol; 2014 Jun; 113(11):1899-903. PubMed ID: 24837271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
